We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIN icon
76
Linde
LIN
$236B
$2.67M 0.07%
7,015
-1,200
-15% -$438K
GLD icon
77
SPDR Gold Trust
GLD
$131B
$2.34M 0.06%
13,134
-300
-2% -$55.1K
GL icon
78
Globe Life
GL
$14B
$2.32M 0.06%
21,125
– –
AWI icon
79
Armstrong World Industries
AWI
$7.37B
$2.22M 0.06%
30,288
-2,120
-7% -$144K
MTD icon
80
Mettler-Toledo International
MTD
$28.1B
$2.22M 0.06%
1,695
-20
-1% -$28.1K
DE icon
81
Deere & Co
DE
$165B
$2.11M 0.06%
5,200
– –
IVV icon
82
iShares Core S&P 500 ETF
IVV
$858B
$1.88M 0.05%
4,217
– –
AMZN icon
83
Amazon
AMZN
$2.44T
$1.87M 0.05%
14,355
-2,175
-13% -$248K
V icon
84
Visa
V
$701B
$1.83M 0.05%
7,700
– –
CVX icon
85
Chevron
CVX
$382B
$1.66M 0.04%
10,522
– –
SLB icon
86
SLB Ltd
SLB
$72.7B
$1.62M 0.04%
33,000
-5,000
-13% -$238K
KO icon
87
Coca-Cola
KO
$383B
$1.56M 0.04%
25,902
-41
-0.2% -$2.55K
EW icon
88
Edwards Lifesciences
EW
$49.4B
$1.43M 0.04%
15,120
– –
HES
89
DELISTED
Hess
HES
$1.22M 0.03%
9,000
– –
VOO icon
90
Vanguard S&P 500 ETF
VOO
$956B
$1.21M 0.03%
2,976
-150
-5% -$57.9K
NEE icon
91
NextEra Energy
NEE
$184B
$1.21M 0.03%
16,328
-33
-0.2% -$2.5K
NDSN icon
92
Nordson
NDSN
$16.4B
$1.19M 0.03%
4,800
– –
CNI icon
93
Canadian National Railway
CNI
$78.5B
$1.17M 0.03%
9,650
-310
-3% -$36.8K
RTX icon
94
RTX Corp
RTX
$290B
$1.08M 0.03%
11,000
– –
GE icon
95
GE Aerospace
GE
$364B
$1.06M 0.03%
12,138
– –
PEG icon
96
Public Service Enterprise Group
PEG
$38.7B
$1.03M 0.03%
16,400
– –
RNR icon
97
RenaissanceRe
RNR
$13.8B
$1.01M 0.03%
5,400
– –
TOST icon
98
Toast
TOST
$18.9B
$987K 0.03%
43,725
-4,500
-9% -$89.8K
D icon
99
Dominion Energy
D
$62B
$982K 0.03%
18,965
– –
CMCSA icon
100
Comcast
CMCSA
$87.3B
$951K 0.02%
22,891
– –
2 3
4
5 6

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.